Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on transformative medicines in three therapeutic areas: oncology, rare disease and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical... Wikipedia
Headquarters: Paris, France
CEO: David Loew (Jul 1, 2020–)
Subsidiaries: Ipsen Pharma, BIOMEASURE Inc., Octagen Corporation, and more
Number of employees: 5,700
Revenue: 2.87 billion EUR (2021)
Founder: Henri Beaufour
Founded: 1929
Source: S&P Global Market Intelligence